Trim 20-25% to 70-75% benchmark weight at $186-190; hard stop at $172
Underweight maintained with 20-25% position trim at $186-190 weakness over 1-2 sessions (not resistance-based $195-200 execution). Bounded directional case: MS PT at $175 below spot, 12.7x forward P/E stretched on 5-7% organic growth, MACD bearish/200 SMA rejection confirmed. Bounded sizing: 9/18 reflection mandates 10-20% trim on quality compounders at recession-level multiples - 20-25% is calibrated toward conservative end. Full Sell rejected - structural floor too thick ($25B+ cash, $12.1B FCF, $1.78B net cash, 24% ROE, 3.6% yield, defended 50 SMA). Buy/Overweight rejected - prior 9/8 Overweight bled -1.3% alpha in near-identical configuration. Price target $175; hard stop $172.
| Position | Action |
|---|---|
| Current position | Trim 20-25% at $186-190 levels over 1-2 trading sessions |
| Post-trim residual | Move to ~70-75% of benchmark weight |
| Deep value flush ($168-175 with MACD histogram turning toward zero, RSI >35, declining volume) | Add up to 0.5% allocation |
| Technical breakout above $197.50 (200 SMA) with MACD positive, volume >40M, RSI >55 | Scale to neutral weight |
| Macro relief: 10Y below 4.5% plus Fed dovish pivot plus constructive technicals | Scale to neutral weight |
| Close below $172 | Hard stop - exit residual position (non-negotiable) |
Accenture's $1B+ Anthropic AI safety partnership transforms the AI-cannibalization thesis into a new multi-billion-dollar TAM opportunity, while the stock trades at a 12.68x forward P/E valuation trough with 17% earnings growth and 3.6% yield — asymmetric upside to $230-280 versus limited downside to $130-150.
| Indicator | Value | Signal |
|---|---|---|
| Close | $186.11 | neutral |
| 10 EMA | $186.48 | neutral |
| 50 SMA | $172.01 | bullish |
| 200 SMA | $197.05 | bearish |
| RSI (14) | 53.40 | neutral |
| Bollinger Middle | $186.48 | neutral |
| Bollinger Upper | $196.92 | bearish |
| Bollinger Lower | $176.04 | bullish |
| MACD | 3.58 | bearish |
| MACD Signal | 4.63 | bearish |
| MACD Histogram | -1.04 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Then: Add up to 0.5% allocation
Fundamentals are far stronger than the stock price implies
↩ rebuts: “Valuation concerns and structural impairment”
EV: +$230-280 (within 12-18 months); +24% to +50% upside from $186 · concedes: 200 SMA is declining and price is below it — the only meaningful structural bear signal; Guggenheim downgraded to Neutral, triggering a -3.3% drop; ACN is down 30% YTD on structural fears; Revenue growth has decelerated to 5-6%
The Anthropic deal is a 0.27% revenue rounding error that validates AI disruption risk rather than mitigating it, the "cheap" multiple reflects structural earnings decline driven by buyback engineering rather than genuine value, and the technical setup shows a falling wedge within a confirmed downtrend with a falling 200 SMA, rolling MACD, and unresolved June 18 structural anomaly—not a basing pattern for buyers.
EV: $145-160
→ vs conservative: Anchoring to fundamentals (3.6% yield, 24% ROE, $12B FCF) while ignoring market sentiment shift; balance sheet strength hasn't prevented 50% decline from highs; dividend yield argument is 'backwards' and creates yield trap risk
→ vs conservative: Holding full position through next 3 months exposes to earnings risk, debt-service costs, opportunity cost, and AI-narrative re-intensification from competitors like IBM and Cognizant
→ vs neutral: Anthropic deal is a 'strategic positioning play dressed up as a transformative catalyst'; market bid up 6-9% on headline and trader is selling into that pop rather than chasing it
| bearish |
| ATR (14) | $7.27 | neutral |
| VWMA (proxy ~20d) | $186.63 | bullish |
Support: 176.04 · 172.01 · 169.98 · 170.43 | Resistance: 196.92 · 197.05 · 200 · 195 · 190.29 · 215 · 220
ACN has declined approximately 44% from ~$330 in September 2024 to $186.11, marked by severe capitulation events including a June 2026 crash on 41.7M volume that remains an unresolved structural anomaly. The stock is in a medium-term basing/recovery phase, with price holding above the 50 SMA ($172.01) but remaining below the declining 200 SMA ($197.05), yielding a neutral long-term trend. Short-term momentum shows mild bearish divergence with MACD below signal and negative histogram, though VWMA confirms volume-supported recovery since July. Key levels: resistance at $196-200 (Bollinger upper/200 SMA), support at $172-176 (50 SMA/Bollinger lower). Overall posture is HOLD with bullish tactical bias while above $172; reduce exposure on close below $169.
Market Cap
$113.9B
P/E (TTM)
14.85
Forward P/E
12.68
PEG Ratio
1.32
Price/Book
3.57
EPS (TTM)
$12.53
Forward EPS
$14.675
Dividend Yield
3.60%
Beta
1.09
52-Week Range
$118.15 – $291.09
Share Price (approx)
~$186
Gross Margin
32.0%
Operating Margin
16.96%
Net Profit Margin
10.66%
ROE
24.4%
ROA
10.9%
Total Assets
$68.81B
Cash & Equivalents
$10.17B
Total Debt
$8.39B
Net Cash Position
+$1.78B
Stockholders' Equity
$31.89B
Goodwill
$25.32B
Working Capital
$7.33B
Current Ratio
1.34
Book Value Per Share
$52.12
Free Cash Flow (TTM)
$12.09B
FCF/Net Income
~155%
Capital Returned (TTM)
~$9.6B
Q3 FY26 Revenue
$18.72B
Q3 FY26 Net Income
$2.34B
Q3 FY26 Diluted EPS
$3.80
Revenue YoY Growth
~5-6%
Capex
~$600M (TTM)
52-Week Position
28th percentile
Goodwill/Assets
36.8%
Strengths
Concerns
Accenture is a high-quality, cash-generative compounder trading near multi-year lows at 12.7x forward P/E, with 17% expected EPS growth, industry-leading 24.4% ROE, and $12.1B TTM free cash flow generating ~155% conversion. The 3.6% dividend yield and ~$9.6B annual capital returns (buybacks + dividends) provide shareholder-friendly downside support, though the primary risk remains structural AI disruption to consulting, partially offset by ACN's own $3B+ AI services franchise. The setup favors accumulation at current levels but near-term volatility remains elevated given macro and AI-narrative overhangs.
Macro: Fed hold regime dominates: 96% probability of zero rate cuts in 2026 (Polymarket, $8.5M volume), rising +2.1pp in one week. Recession odds falling: US 6% (-3.0pp), UK 4% (-6.0pp), Japan 4% (-2.5pp). Cross-asset: S&P 500 favored at 52% probability as best 2026 performer (vs. Gold 10%, Bitcoin 32%); S&P hitting $5,200 low in December priced at only 3%. No-cut regime is supportive for IT services multiples (stable discount rates, duration-asset benefit) but reflects sticky inflation/incremental tightness that historically pressures corporate IT budgets — a tension to monitor. FRED macro data unavailable; all macro context derived from prediction markets.